Immunovia AB (publ)
F:1YR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Immunovia AB (publ)
F:1YR
|
SE |
|
W
|
White Pearl Technology Group AB
STO:WPTG B
|
SE |
|
G
|
GRC International Group PLC
LSE:GRC
|
UK |
|
F
|
Full Apex (Holdings) Ltd
SGX:BTY
|
HK |
|
Adamas One Corp
OTC:JEWL
|
US |
|
S. P. Apparels Ltd
NSE:SPAL
|
IN |
Immunovia AB (publ)
Immunovia AB engages in the development of methods for diagnosing complex forms of cancer and autoimmune diseases. The company is headquartered in Lund, Skane and currently employs 65 full-time employees. The company went IPO on 2015-12-01. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.
Immunovia AB engages in the development of methods for diagnosing complex forms of cancer and autoimmune diseases. The company is headquartered in Lund, Skane and currently employs 65 full-time employees. The company went IPO on 2015-12-01. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
